Medical devices continue to be a strong growth driver for Abbott, as the company battles its ongoing sales slump in diagnostics, which accelerated in the third quarter. Third-quarter revenue for its ...

The Food and Drug Administration issued a warning late Thursday over the accuracy of the highly-touted Abbott instant coronavirus test. Specifically, the FDA said that the test has caused some false ...

(Reuters) -Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, and the government's foreign ...

In late March, Trump hailed the launch of Abbott Laboratories’ ID NOW test at a Rose Garden event and embraced its widespread use at the White House to keep the deadly virus at bay. The president ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Abbott Laboratories narrowed its full-year outlook as sales of COVID-19 tests slide. COVID-19 test sales in the second quarter dropped 46% from the year before. Second-quarter earnings and revenue ...